Suchergebnisse - "Cimadamore, Alessia"

PubPharm (215)

11

Histopathology of Prostate Cancer and its Precursors

enthalten in: Applied immunohistochemistry & molecular morphology : AIMM | 2023

von Montironi, R. | Cimadamore, A. | Mazzucchelli, R. | +3

12

Frequent Telomerase Reverse Transcriptase Promoter and Fibroblast Growth Factor Receptor 3 Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2023

von Cheng, L. | Lopez-Beltran, A. | Wang, M. | +11

13

Vascular Enlargement as a Predictor of Nodal Involvement in Bladder Cancer

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Borgheresi, A. | Agostini, A. | Sternardi, F. | +9

14

Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators

enthalten in: BJU international | 2023

von Del Giudice, F. | D'Andrea, D. | Pradere, B. | +18

15

The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy

enthalten in: Urologic oncology | 2023

von Galosi, A. | Milanese, G. | Montesi, L. | +5

16

Clinical utility of checkpoint inhibitors against metastatic bladder cancer : overcoming challenges to find a way forward

enthalten in: Expert opinion on biological therapy | 2023

von Bilé-Silva, A. | Lopez-Beltran, A. | Blanca, A. | +6

17

Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype

enthalten in: Cancers | 2023

von Blanca, A. | Lopez-Beltran, A. | Lopez-Porcheron, K. | +6

18

Apalutamide or enzalutamide in castration-sensitive prostate cancer : a number needed to treat analysis

enthalten in: Tumori | 2023

von Santoni, M. | Massari, F. | Rizzo, A. | +4

19

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)

enthalten in: Journal for immunotherapy of cancer | 2023

von Atkins, M. | Jegede, O. | Haas, N. | +17

20

Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs) : Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis

enthalten in: Cancers | 2023

von Del Giudice, F. | Asero, V. | Bologna, E. | +35